Treatment cost of narcolepsy with cataplexy in Central Europe

Overview of attention for article published in Therapeutics and Clinical Risk Management, November 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

patent: 18 patents

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 24 Mendeley

So far, Altmetric has seen 18 patents that reference this research output.

Dove Medical Press

Article Metrics

Treatment cost of narcolepsy with cataplexy in Central Europe

About this Attention Score

Mentioned by

Citations

Readers on

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Grant US-11896572-B2

United States of America

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Grant US-11839597-B2

United States of America

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Grant US-11826335-B2

United States of America

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Grant US-11779557-B1

United States of America

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Grant US-11766418-B2

United States of America

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Grant US-11602512-B1

United States of America

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Grant US-11602513-B1

United States of America

Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

Grant US-11583510-B1

United States of America

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Grant US-11504347-B1

United States of America

Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state

Grant US-11400065-B2

United States of America

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Grant US-11065224-B2

United States of America

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Grant US-11052061-B2

United States of America

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Grant US-11000498-B2

United States of America

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Grant US-10973795-B2

United States of America

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Grant US-10952986-B2

United States of America

Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state

Grant US-10925844-B2

United States of America

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Grant US-10736866-B2

United States of America

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Grant US-10272062-B2

United States of America